AAM
VANI icon

Azzad Asset Management’s Vivani Medical VANI Stock Holding History

Azzad Asset Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-442
Closed -$12.8K – 311
2017
Q1 		$12.8K Buy
+442
New +$16.9K ﹤0.01% 253

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CD
Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Azzad Asset Management's VANI Position: Q2 2017 in Review

Azzad Asset Management sold out of Vivani Medical (VANI) in Q2 2017, closing a stake of 442 shares — an estimated $12.8K sold.

Azzad Asset Management first reported a position in VANI in Q1 2017 and held it in 1 quarter. The position peaked at $12.8K in Q1 2017. 44 funds tracked by Wall St. Rank hold VANI as of Q2 2017.

  • Azzad Asset Management reported no remaining Vivani Medical position as of Q2 2017 after selling out during the quarter.
  • Azzad Asset Management sold 442 Vivani Medical shares in Q2 2017, an estimated $12.8K.
  • Azzad Asset Management first reported a position in Vivani Medical in Q1 2017 and held it in 1 quarter.
  • Azzad Asset Management's Vivani Medical position peaked at $12.8K in Q1 2017.
  • 44 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2017.

Based on Azzad Asset Management's 13F filing for Q2 2017, filed 3 Apr 2024.